Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial

The Journal of Sexual Medicine
Hyun Jun ParkNam C Park

Abstract

Mirodenafil is a newly developed selective phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED). To evaluate the efficacy, safety and tolerability of mirodenafil in the treatment of ED in Korean men with diabetes. A multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study was conducted with 112 subjects who were randomized to either placebo or mirodenafil 100 mg on demand for 12 weeks. Primary efficacy variable was the erectile function (EF) domain scores of the International Index of Erectile Dysfunction (IIEF) questionnaire. Secondary efficacy variables included change in the scores of IIEF question 3 and 4 (IIEF Q3 and Q4) from baseline, change in all domain scores in the IIEF from baseline, Sexual Encounter Profile questions 2 and 3 (SEP2 and SEP3), the Global Assessment Question (GAQ) and the Life Satisfaction Checklist (LSC). After 12 weeks of treatment, mirodenafil group showed significantly greater change in the IIEF-EF domain score from baseline compared with the placebo group (9.3 vs. 1.4, P < 0.0001). The changes from baseline in the mirodenafil group in IIEF Q3 (1.7 vs. 0.4, P < 0.0001) and Q4 (1.7 vs. 0.3, P < 0.0001) were higher compared with t...Continue Reading

References

Oct 7, 1997·International Journal of Impotence Research·A R Fugl-MeyerK S Fugl-Meyer
Aug 2, 2002·International Journal of Impotence Research·R C RosenN Gendrano
Nov 28, 2002·Diabetes Care·Iñigo Sáenz de TejadaJeffrey T Emmick
Jun 19, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Shaohua ChangMichael E DiSanto
Jan 26, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·N H ChoD S Choi
Aug 11, 2007·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Srdan PopovićPredrag Dordević
Feb 23, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·D HatzichristouS Liang
Feb 13, 2009·The Journal of Sexual Medicine·Lasantha S Malavige, Jonathan C Levy
May 21, 2009·The Journal of Sexual Medicine·Bang-Ping JiannJenn-Kuen Lee
May 29, 2009·The Journal of Sexual Medicine·Chih-Chen LuJenn-Kuen Lee
Jan 15, 2010·BMC Public Health·Tamara PoljicaninGorka Vuletić Mavrinac

❮ Previous
Next ❯

Citations

Sep 7, 2014·Current Diabetes Reports·Konstantinos Hatzimouratidis, Dimitrios Hatzichristou
Jul 1, 2014·Expert Opinion on Pharmacotherapy·Grant P RedrowRun Wang
Jan 12, 2016·Expert Opinion on Drug Safety·Eugenio VentimigliaAndrea Salonia
Jan 25, 2013·The Journal of Sexual Medicine·Hartmut PorstUNKNOWN ISSM Standards Committee for Sexual Medicine
Aug 28, 2014·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Jinhong LiPing Han
Sep 30, 2016·Expert Opinion on Pharmacotherapy·Igor VoznesenskyWayne J G Hellstrom
Apr 2, 2016·Therapeutic Advances in Urology·Min Chul Cho, Jae-Seung Paick
Aug 15, 2018·Expert Opinion on Pharmacotherapy·Ahmed I El-Sakka
Sep 18, 2013·The World Journal of Men's Health·Ji Kan RyuSoo Woong Kim
May 30, 2014·The World Journal of Men's Health·Hyun Jun ParkNam Cheol Park
Nov 14, 2013·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Wan DuHui Ding
Jun 18, 2014·The Cochrane Database of Systematic Reviews·Anne M Gadomski, Melissa B Scribani
Aug 14, 2019·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Alev OnderSerap Gur
Jun 5, 2013·The Cochrane Database of Systematic Reviews·Ricardo M FernandesLisa Hartling
Dec 5, 2020·Expert Opinion on Pharmacotherapy·Ahmed M BakrAhmed I El-Sakka
Aug 17, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Nelisiwe Prenate MasukuSogolo Lucky Lebelo
Sep 14, 2021·Diabetes/metabolism Research and Reviews·Giuseppe DefeudisDaniele Gianfrilli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.